Advertisements

Babylon Health Gets $2 Billion Valuation With New Funding That Will Help It Expand In U.S.

Babylon Health, a U.K.-based startup whose fast growth has been shadowed by concerns about the efficacy of its telemedicine apps, has raised $550 million in Series C funding, elevating the company to unicorn status. Saudi Arabia’s Public Investment Fund (PIF), which invest on behalf of the Saudi Arabian government, led the round that valued the company at $2 billion with a total of $635 million raised.

The new capital will enable the company to expand into more markets including the U.S. and Asia, Babylon said, and it will also bolster its artificial intelligence capabilities on the platform, which serves 4.3 million users worldwide. An unnamed U.S health insurer and a fund of global reinsurer Munich Re also invested. Vostok New Ventures, which already holds a 10% stake in Babylon, previously said it would participate in the new round, as did Sweden’s Kinnevik.

With an aim of cutting healthcare costs and broadening access, Babylon secured deals with Britain’s National Health Service with its apps to replace local doctor visits with video consultations and a chatbot that doled out advice on whether to see a doctor. It released a new artificially intelligent chatbot that promised to give diagnostic advice on common ailments, without human interaction. Its progress, however, was stuttered by doubts about the services’ abilities. Interviews with current and former Babylon staff and outside doctors revealed broad concerns that the company has rushed to deploy software that had not been carefully vetted, then exaggerated its effectiveness, Forbes revealed in December. The company disputed those claims, saying its software goes through many clinical tests.  The company also came under fire for failure to follow up with patients receiving mental health treatment. At the time, Babylon blamed problems with the NHS referral system.

Any blunders don’t seem to have slowed the company’s momentum.

Led by CEO and Founder Ali Parsa, an Iranian-born former banker, Babylon has also secured contracts with Prudential and Samsung. It says it now delivers 4,000 clinical consultation a day, and one patient interaction every 10 seconds.

“We have a long way to go and a lot still to deliver,” Parsa said in a statement. “While the burden of healthcare is global, the solutions have to be localized to meet the specific needs and culture of each country.”

Follow me on Twitter. Send me a secure tip.

I serve as assistant editor for Forbes Innovation, covering cybersecurity and venture capital. I have covered politics at POLITICO, entertainment for Time Out New York, but my most fascinating beat has been covering the intersection of technology, finance, and entrepreneurship. I’m also an alumna of CUNY Graduate School of Journalism, and the University of Washington. Email tips to mmelton@forbes.com

Source: Babylon Health Gets $2 Billion Valuation With New Funding That Will Help It Expand In U.S.

Advertisements

Groupon Made Eric Lefkofsky A Billionaire—His Cancer-Fighting Startup Is Worth Far More

Eric Lefkofsky hasn’t taken a science class since college. But as he meanders through the Chicago lab of Tempus, his medical startup, he presents an air of expertise. “One thing you can see right off the bat is the purple staining of this cell,” he says, pointing to the pathology slide of a patient with breast cancer. He walks past vials of lysis buffer and a $1 million genomic sequencer. “Tempus is attempting to bring the power of artificial intelligence to healthcare,” he says. “The first step in all that is data.”

Assembling data was the first step in Lefkofsky’s other ventures. The 49-year-old has launched five companies worth at least $250 million apiece, each promising to transform an industry by using big data. His best-known venture is Groupon; despite the deals site’s disappointing share price, Lefkofsky is worth an estimated $2.7 billion.

Tempus is predicated on the theory that information, lots of it, will enable doctors to personalize cancer treatments and make them more effective. A doctor treating a patient with lung cancer might send a tumor sample to Tempus for genomic sequencing. Tempus identifies a mutation in the gene for epidermal growth factor receptor, which causes cells to grow and divide too much. With that, the doctor prescribes a targeted therapy that can have better results than chemotherapy.

So far the 700-employee company has raised $520 million (Lefkofsky put in $100 million). The lavish $3.1 billion valuation suggests investors expect his approach to make a big score, starting with cancer, then against chronic conditions like depression and diabetes. But precision medicine is a nascent field. Tempus, on its own or with a research partner, has published fewer than 20 peer-reviewed manuscripts since its founding four years ago. A competitor, sequencing firm Foundation Medicine, has published over 400 in 9 years.

While the cost of sequencing has dropped, it still runs $1,000 to $5,000 per analysis, and Tempus loses money doing it. Tempus also licenses its library of anonymized data to drug companies, insurers and researchers. Lefkofsky won’t reveal revenues, but says it gets seven-figure fees from seven of the ten largest cancer drug companies.

Lefkofsky got the entrepreneurial bug at the University of Michigan, where he studied history and made money selling carpets. In 2001, he cofounded InnerWorkings (marketing), then Echo Global Logistics (transportation) and Mediaocean (advertising software). One of Lefkofsky’s hires, Andrew Mason, pitched an idea for a business focused on “collective action.” Lefkofsky invested $1 million in what became Groupon. A year after its 2008 founding, it booked $14.5 million in revenue; in 2011, it generated $1.6 billion.

“It certainly feels like my entire career has led to this point,” Lefkofsky says. “I hope this will be my legacy project.”

Lefkofsky spent a few years dabbling on other projects, including Uptake (predictive analytics for heavy industry). “I always knew back then, [with] those businesses, that I would be in and out,” he says.

In 2014, Lefkofsky’s wife, Liz, was diagnosed with breast cancer. “I was just perplexed at how little data had permeated her care,” he says. That experience ultimately launched Tempus. (Liz has “been taking it one day at a time,” Lefkofsky says.)

Yet again, Lefkofsky needed data. But some researchers were initially hesitant to share. “They wanted us to basically send all our samples there for all our patients” in the future, says John McPherson, deputy director of the UC Davis Comprehensive Cancer Center. “But we took a more cautious approach.” They ran a head-to-head comparison involving gastrointestinal cancer between Tempus and Foundation Medicine; Tempus fared well.

                       

In 2017 Tempus reached a licensing agreement with the American Society of Clinical Oncology to extract and organize data from 1 million patient records. Today the company says it already works with 30% of U.S. oncologists; many send patient records and biopsies to Tempus for analysis. Tempus hopes to sequence 120,000 genomic samples for doctors this year.

Even with that data, Tempus faces stiff competition. Last year Swiss drug giant Roche spent $4.3 billion acquiring Foundation Medicine and big data firm Flatiron Health. Another startup, Concerto HealthAI, backed by billionaire Romesh Wadhwani, has access to many of the same records as Tempus.

                           

Doctors at UC Davis, McPherson says, have only sent about 100 samples to Tempus, considerably fewer than they’ve sent to Foundation. “I think they were a little baffled by the amount of data that came back [from Tempus],” McPherson says. Clinicians “tend to take the easier route just to save time. But there are several clinicians that are now working fairly closely on the research side with them.”

Lefkofsky remains supremely optimistic. “It certainly feels like my entire career has led to this point,” he says. “I hope this will be my legacy project.”

I’ve been a reporter at Forbes since 2016. Before that, I spent a year on the road—driving for Uber in Cleveland, volcano climbing in Guatemala, cattle farming in Urugua…

Staff writer at Forbes. Email me at mtindera@forbes.com and follow me on twitter @mtindera07.

Source: Groupon Made Eric Lefkofsky A Billionaire—His Cancer-Fighting Startup Is Worth Far More

It’s Alive! Facebook’s Surprising Video Standout Is A Horror Movie Startup

Like a proud parent, Jack Davis has covered the refrigerator in his Wilshire Boulevard office with artwork. But these aren’t crayon-drawn stick figures of Mom and Dad. They’re the stuff of nightmares—a demonic entity with shark teeth, a cannibal with thorns sprouting from his head, a tree that likes to disembowel its victims.

The gruesome creatures crawled out of the imagination of Davis’ Crypt TV, a digital studio that aspires to become the Marvel of monsters for mobile. Davis, 27, has raised $11 million from investors including Hollywood producer Jason Blum (Us, Ma), media mogul Shari Redstone’s Advancit Capital, Huffington Post cofounder Kenneth Lerer and NBCUniversal. The four-year-old Los Angeles studio, which creates horror videos for social networks, is on track to bring in about $20 million in revenue this year through production deals, running ads for films like Crawl and selling merchandise.

When he started, “no one was doing scary for mobile,” Davis says. That signaled a missed opportunity. “This is a huge genre. It has a solid fan base, and scary movies are very, very big.”

The Golden Age of streaming has birthed Netflix competitors that cater to nearly every genre, from U.K. shows on Britbox to anime on Crunchyroll and, yes, horror on Shudder and Screambox. At the same time, studios like Elisabeth Murdoch’s Vertical Networks have built audiences that are reached primarily through mobile-first social networks such as Snapchat and Instagram, which more than a billion people visit each month.

Davis and Crypt TV cofounder Eli Roth, the film director and producer who developed Netflix’s first horror series, Hemlock Grove, bet that an audience who loved films like Jordan Peele’s Oscar-nominated Get Out would snap up suspense and horror on the small screen, too.

It’s an intuition that’s paying off. Crypt TV said on Friday that it had reached a deal with Facebook to develop five series exclusively for Facebook Watch, its on-demand video service. The deal extends a partnership started in 2018, when Facebook green-lighted a 15-episode series based on Crypt’s short film The Birch.

Facebook has been paying as much as $25 million for these original shows, though the bulk of them cost $3 to $5 million, according to a person familiar with the matter. Forbes estimates the new Crypt TV deal is valued at less than $20 million. Neither party would disclose the terms of the partnership.

Facebook might seem an unlikely place to screen monster movies for Generation Z and younger Millennials, who make up nearly half of Crypt TV’s audience. One Pew Research Center survey last year found that the world’s largest social network is no longer the most popular hangout for teens, a big drop from earlier in the decade. Plus, Facebook Watch has struggled to gain traction. A year after Facebook CEO Mark Zuckerberg launched Watch to better compete with Google’s YouTube and Snapchat’s Discover, only half of Facebook users had ever heard of it, says The Diffusion Group, a media research consultancy.

Still, momentum is gathering for shows that capitalize on the network’s power to amass communities to talk about shared interests—say, Jada Pinkett Smith’s talk show, Red Table Talk, or Sorry for Your Loss, a drama on grief starring Elizabeth Olsen. Facebook says more than 140 million people each day spend at least a minute viewing Watch videos.

“It’s very hard to say that a platform … (of) two-plus billion people on it doesn’t have young people on it,” says Matthew Henick, Facebook’s head of content planning and strategy. “What Crypt does incredibly well is—because they’re able to tell their stories through many different modes or, in this case, products—they’re able to find those audiences and pull them in.”

Crypt TV taps into a community that likes to be scared. Horror has been reeling in fans on the big screen: The genre brought in a record $1 billion in box office sales in 2017, according to Comscore.

Some fans want to get their goose bumps for free. Thanks to The Birch, which was viewed 26 million times on Facebook, the studio now has 9.75 million followers, or more than triple its YouTube audience. On Davis’ fridge hang mementos from fans. One shared a photo of her tattoo—it’s of the Look-see, a creature with no eyes and flesh that’s been stitched together.

“Young people have so much emotion,” Davis says. A scary story “provides an amazing, permissive structure to take on deep emotional issues.”

A fortuitous encounter at a dinner party hosted by his parents in West Los Angeles led to the creation of Crypt TV. Then a student at Duke University, Davis found himself sitting next to Roth and began reciting dialogue from Roth’s portrayal of the bat-wielding Nazi killer Donny Donowitz in Inglourious Basterds.

The conversation turned to Davis’ career plans. The sociology and political science major said he hoped to launch his own company, capitalizing on the dramatic shift in media viewing habits he’d observed during his four years in college. Roth had a suggestion.

“I said, ‘You know that audience that’s going to see horror movies now’—because obviously now horror has exploded—‘They’re all on their phones,’” Roth recalls. “What is the next generation of characters? Who is creating the new Freddy Krueger? Is there a way to launch a Freddy? A Jason? A Michael Myers? A Chucky? Just on your phone?”

Roth introduced him to Blum, who became Crypt TV’s earliest investor and served as a mentor to the company’s 23-year-old founder.

An early success was #6SecondScare, an October 2014 online competition that encouraged users of Vine, Twitter’s six-second video service, to upload their scariest videos.

Roth lent his name to the contest and coaxed Hollywood celebrities including Quentin Tarantino and High School Musical’s Vanessa Hudgens to promote it and serve as judges. #6SecondScare attracted 20,000 submissions and ended up featured on ABC’s Good Morning America.

In the summer of 2015, Davis’ team launched Snapchat Murder Mystery, a show that gathered ten social media influencers to a mansion party, then killed off their characters in an Agatha Christie-styled whodunit. A year later came Crypt TV’s breakthrough moment with The Birch. The four-minute video follows a terrified schoolboy who summons an ancient being in the woods to dispense a particularly bloody form of retribution on the boy’s tormentor.

Davis faces his own monster lurking in the dark: Quibi. The mobile video subscription service comes with a Hollywood pedigree, a $1 billion cash horde and some of the best-known filmmakers in horror, Guillermo del Toro (The Shape of Water, Pan’s Labyrinth) and Sam Raimi (Evil Dead), as well as Blum, producing original content.

Quibi launches in April—though Crypt TV, in classic horror film fashion, has gotten a running start.

Follow me on Twitter. Send me a secure tip.

I’m a Los Angeles-based senior editor for Forbes, writing about the companies and people behind the biggest disruption in entertainment since cable TV: streaming video

Source: It’s Alive! Facebook’s Surprising Video Standout Is A Horror Movie Startup

Zuckerberg’s Big Hopes, a new Huawei sting, VPN truths, a five-year bet on Bitcoin, the Captcha puzzle, and more — The Overspill: when there’s more that I want to say

Afraid so: the machines are now able to beat us at this game too. CC-licensed photo by Chris on Flickr. Ahead of No. 1,000, send in your three favourite links – leave a comment, email or DM me. Popular so far: Why drowning doesn’t look like drowning (May 2018); why I hope we don’t find […]

via Start Up No.996: Zuckerberg’s big hopes, a new Huawei sting, VPN truths, a five-year bet on Bitcoin, the Captcha puzzle, and more — The Overspill: when there’s more that I want to say

Healthcare Startups Have Raised More This Year Than in 2012 And 2013 Combined – Michela Tindera

1.jpg

With two months left in 2018, healthcare startups have already raised more in VC funding this year than they did in all of 2012 and 2013 combined, according to an analysis conducted for Forbes by Pitchbook. Venture capitalists have poured more than $26 billion into health startups this year. In 2012 and 2013 combined, the sector raised $22.3 billion in 12 months. So far this year that $26.3 billion has been spread among 1,540 deals, which is slightly less than half the 3,103 deals that took place in 2012 and 2013………

Read more: https://www.forbes.com/sites/michelatindera/2018/11/02/healthcare-startups-have-raised-more-this-year-than-in-2012-and-2013-combined/#521a6b867ac7

 

 

 

 

Your kindly Donations would be so effective in order to fulfill our future research and endeavors – Thank you

The Startup Postmates and Visa Use To Watch Their Language Just Raised $11.5 Million To Expand – Alex Konrad

1.jpg

When the startup Qordoba first met with California venture capitalists to share its software idea, its founders faced an uphill battle for attention. Its chief executive was a female ex-banker. Its chief technology officer was Syrian and had taught himself English. And their business was based in Dubai. But Qordoba was operating in a market that resonated across geographies: translation. Initially focused on helping businesses manage local teams to translate their projects and copywriting to different languages…….

Read more : https://www.forbes.com/sites/alexkonrad/2018/10/11/the-startup-postmates-and-visa-use-to-keep-their-language-consistent-just-raised-115-million-to-expand/#3d45b10a768c

 

 

 

Your kindly Donations would be so effective in order to fulfill our future research and endeavors – Thank you

 

%d bloggers like this:
Skip to toolbar